- DNA Microarrays
- Lab on a chip/Microfluidics
- Protein Microarrays
- Tissue Biochip
- Carbohydrate Biochips
Lab on Chips Market size was valued at USD 4,160.8 million in 2022 and is poised to grow at a CAGR of 8.9% from 2023-29. On the perspective of life sciences detection of bloodstream cancer, screening of HIV, crystallization studies are the drivers which help in the growth of global lab on chip market. There are few factors which act as restraint such as limited technician knowledge, high cost and availability of the alternative which hamper the growth. Intense opportunity is provided by biotechnology and life science testing for the adequate growth of global lab on chip market.
Study Period
2024-2030Base Year
2023CAGR
8.9%Largest Market
North AmericaFastest Growing Market
Asia-Pacific
It is noticed that the global lab on chip market has a significant market growth rate on the perspective of rising demand of personalized medicines and other cancer therapies. Global market for personalized medicine therapeutics was estimated to be worth some 60 billion U.S. dollars, forecasting a growth up to 140 billion dollars by 2022. Cancer is the second leading cause of death globally, and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer. Hence all these contribute towards the sustainable development of global lab on chip market.
By Product Type
By Application
By End User
By Geography
The lab on chips market size was valued at USD 4,160.8 million in 2022
Advantages of lab-on-a-chip technology
Asia Pacific is the fastest-growing for lab on chips market